Epilepsie Instellingen Nederland Stichting

Zwolle 18 trials 10 recruiting

18 Registered trials

10 Currently recruiting

Organisation

Epilepsie Instellingen Nederland Stichting

Location

Zwolle, Netherlands

Identifier

ORG-100029655

Address

Dokter Denekampweg 20, 8025 BV, Netherlands

Departments

#1401
#1401: Neurology
Epilepsy
N/A
Neurologie
Neurology
Pediatric Neurology
Polyclinic Epilepsy

Clinical trials at this site (18)

Search interface

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1 Pending

2025-523911-13-00 Narcolepsy Type 1 5
A Phase 3 Open-Label Study to Investigate bexicaserin (LP352) in Children and Adults with Developmental and Epileptic Encephalopathy Recruiting

2024-514974-39-00 Developmental and Epileptic Encephalopathies (DEEs) 5 2025-10-10
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach Recruiting

2023-507843-12-01 Refractory Epilepsy 5 2025-01-24
A Phase 3, placebo-controlled study to investigate LP352 in children and adults with Developmental and Epileptic Encephalopathies Recruiting

2024-516412-17-00 Developmental and Epileptic Encephalopathies (DEE) 5 2025-08-26
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Recruiting

2025-520981-23-00 Idiopathic Hypersomnia (IH) 4 2025-08-26
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) Recruiting

2024-514937-39-00 Dravet Syndrome 5 2025-05-20
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia Recruiting

2024-519822-18-00 Narcolepsy Type 1, Type 2 and Idiopathic Hypersomnia 10 2025-05-14
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Refractory Focal Onset Epilepsy 4 2024-12-18
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508539-30-00 Refractory Focal Onset Epilepsy 4 2024-10-10
A Study to Examine the Efficacy and Safety of ZX008 in Subjects with CDKL5 Deficiency Disorder Ended

2023-506269-78-00 CDKL5 Deficiency disorder 5 2023-06-20
A Trial to Evaluate the Long-term Safety and Tolerability of TAK-861 Ended

2023-508462-15-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 10 2023-04-27
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2 Ended

2024-515452-20-00 Narcolepsy Type 2 4 2025-04-01
A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 Ended

2024-511112-24-00 Narcolepsy Type 1 4 2025-01-17
A Study to Evaluate the Efficacy and Safety of TAK-861 for the Treatment of Narcolepsy with Cataplexy Ended

2023-508465-32-00 Narcolepsy with Cataplexy (Narcolepsy Type 1) 5 2024-09-03
Open-label extesnion study of soticlestat in Dravet and Lennox-Gastaut Syndromes Ended

2022-502802-34-00 Dravet and Lennox-Gastaut Syndromes 5 2022-04-05
An extension study to learn about the long-term safety of fenfluramine hydrochloride for seizures in children and adults with rare seizure d… Ended

2024-515680-61-00 Dravet syndrome or Lennox-Gastaut syndrome 5 2020-02-07
EQU-001 as an Add-On Drug for People with Focal Seizures while on Medication Ended

2022-500302-18-00 Epilepsy 4
The ENACT Trial: A Randomized, double-blind, placebo-controlled adjunctive treatment trial to evaluate the efficacy and safety of ENX-101 in… Expired

2022-501028-95-00 focal (partial onset) epilepsy 4